Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars

References

• KleerCGvan GolenKLMerajverSDMolecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinantsBreast Cancer Res20002642342911250736
   PubMedGoogle Scholar
• WoodwardWAInflammatory breast cancer: unique biological and therapeutic considerationsLancet Oncol20151615e568e57626545845
   PubMedGoogle Scholar
• MatroJMLiTCristofanilliMInflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcomeClin Breast Cancer20151511725034439
   PubMedGoogle Scholar
• CristofanilliMValeroVBuzdarAUInflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique diseaseCancer200711071436144417694554
   PubMed Web of Science ®Google Scholar
• RobertsonFMBondyMYangWInflammatory breast cancer: the disease, the biology, the treatmentCA Cancer J Clin201060635137520959401
   PubMed Web of Science ®Google Scholar
• VermeulenPBvan GolenKLDirixLYAngiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancerCancer201011611 Suppl2748275420503405
   PubMedGoogle Scholar
• AroraJSauerSJTarpleyMInflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategiesOncotarget2017816258482586328460441
   PubMedGoogle Scholar
• WoodwardWACristofanilliMInflammatory breast cancerSemin Radiat Oncol200919425626519732690
   PubMedGoogle Scholar
• NathSDeviGRThree-dimensional culture systems in cancer research: focus on tumor spheroid modelPharmacol Ther20161639410827063403
   PubMed Web of Science ®Google Scholar
• RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsJ Cell Biol2010188675920231381
   PubMed Web of Science ®Google Scholar
• KolhatkarRLoteAKhambatiHActive tumor targeting of nanomaterials using folic acid, transferrin and integrin receptorsCurr Drug Discov Technol20118319720621696360
   PubMedGoogle Scholar
• GaoNChenYLiLShape-dependent two-photon photoluminescence of single gold nanoparticlesJ Phys Chem C2014118251390413911
   Web of Science ®Google Scholar
• ShammasRLFalesAMCrawfordBMHuman adipose-derived stem cells labeled with plasmonic gold nanostars for cellular tracking and photothermal cancer cell ablationPlast Reconstr Surg20171394900e910e
   PubMed Web of Science ®Google Scholar
• YuanHKhouryCGHwangHWilsonCMGrantGAVo-DinhTGold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imagingNanotechnology201223707510222260928
   PubMed Web of Science ®Google Scholar
• NiuWChuaYAAZhangWHuangHLuXHighly symmetric gold nanostars: crystallographic control and surfaceenhanced Raman scattering propertyJ Am Chem Soc201513733104601046326259023
   PubMed Web of Science ®Google Scholar
• YuanHFalesAMVo-DinhTTAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradianceJ Am Chem Soc201213428113581136122734608
   PubMed Web of Science ®Google Scholar
• KoljaTSalamonJSzwargulskiPIncreasing the sensitivity for stem cell monitoring in system-function based magnetic particle imagingPhys Med Biol20166193279329027032447
   PubMedGoogle Scholar
• Ariza de SchellenbergerAKratzHFarrTDLabeling of mesenchymal stem cells for MRI with single-cell sensitivityInt J Nanomedicine2016111517153527110112
   PubMed Web of Science ®Google Scholar
• LiuSTayLMAnggaraRLong-term tracking mesenchymal stem cell differentiation with photostable fluorescent nanoparticlesACS Appl Mater Interfaces2016819119251193327124820
   PubMedGoogle Scholar
• LiuYYuanHFalesAMRegisterJKVo-DinhTMultifunctional gold nanostars for molecular imaging and cancer therapyFront Chem201535126322306
   PubMedGoogle Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• VinogradovSVBronichTKKabanovAVNanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cellsAdv Drug Deliv Rev200254113514711755709
   PubMed Web of Science ®Google Scholar
• WhiteheadKAMatthewsJChangPHNirouiFDorkinJRSevergniniMAndersonDGIn vitro–in vivo translation of lipid nanoparticles for hepatocellular siRNA deliveryACS nano2012686922692922770391
   PubMedGoogle Scholar
• ArvizoRBhattacharyaRMukherjeePGold nanoparticles: opportunities and challenges in nanomedicineExpert Opin Drug Deliv20107675376320408736
   PubMed Web of Science ®Google Scholar
• LeeJLillyGDDotyRCPodsiadloPKotovNAIn vitro toxicity testing of nanoparticles in 3D cell cultureSmall20095101213122119263430
   PubMed Web of Science ®Google Scholar
• SambaleFLavrentievaAStahlFThree dimensional spheroid cell culture for nanoparticle safety testingJ Biotechnol201520512012925595712
   PubMed Web of Science ®Google Scholar
• EdmondsonRBroglieJJAdcockAFThree-dimensional cell culture systems and their applications in drug discovery and cell-based biosensorsAssay Drug Dev Technol201412420721824831787
   PubMed Web of Science ®Google Scholar
• LovittCJShelperTBAveryVMAdvanced cell culture techniques for cancer drug discoveryBiology (Basel)20143234536724887773
   PubMedGoogle Scholar
• ImamuraYMukoharaTShimonoYComparison of 2D- and 3D-culture models as drug-testing platforms in breast cancerOncol Rep20153341837184325634491
   PubMed Web of Science ®Google Scholar
• NygaACheemaULoizidouM3D tumour models: novel in vitro approaches to cancer studiesJ Cell Commun Signal20115323924821499821
   PubMedGoogle Scholar
• MehtaGHsiaoAYIngramMLukerGDTakayamaSOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacyJ Control Release2012164219220422613880
   PubMed Web of Science ®Google Scholar
• DamDHMLeeJHSiscoPNDirect observation of nanoparticle – cancer cell nucleus interactionsACS Nano2012643318332622424173
   PubMed Web of Science ®Google Scholar
• BarbosaSTopeteAAlatorre-MedaMTargeted combinatorial therapy using gold nanostars as theranostic platformsJ Phys Chem C2014118452631326323
   Web of Science ®Google Scholar
• AirdKMDingXBarasATrastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expressionMol Cancer Ther200871384718202008
   PubMed Web of Science ®Google Scholar
• WilliamsKPAllensworthJLIngramSMQuantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitizationCancer Lett20133371778923689139
   PubMedGoogle Scholar
• AirdKMGhanayemRBPeplinskiSLyerlyHKDeviGRX-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitorMol Cancer Ther2010951432144220406946
   PubMed Web of Science ®Google Scholar
• SchneiderCARasbandWSEliceiriKWNIH Image to ImageJ: 25 years of image analysisNat Methods20129767167522930834
   PubMed Web of Science ®Google Scholar
• BrownDAChouYFBeyguiREDunnJCWuBMGelatin-embedded cell–polymer constructs for histological cryosectioningJ Biomed Mater Res B Appl Biomater2005721798515389500
   PubMedGoogle Scholar
• PeetlaCVijayaraghavaluSLabhasetwarVBiophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticlesAdv Drug Deliv Rev20136513–141686169824055719
   PubMed Web of Science ®Google Scholar
• VijayaraghavaluSPeetlaCLuSLabhasetwarVEpigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functionsMol Pharm2012992730274222817326
   PubMedGoogle Scholar
• NairSAldrichAJMcDonnellEImmunologic targeting of FOXP3 in inflammatory breast cancer cellsPLoS One201381e5315023341929
   PubMedGoogle Scholar
• EvansMKSauerSJNathSRobinsonTJMorseMADeviGRX-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicityCell Death Dis20167e207326821068
   PubMed Web of Science ®Google Scholar
• DeSantisCSiegelRBandiPJemalABreast cancer statistics, 2011CA Cancer J Clin201161640941821969133
   PubMed Web of Science ®Google Scholar
• NewmanEAGuestABHelvieMAChanges in surgical management resulting from case review at a breast cancer multidisciplinary tumor boardCancer2006107102346235116998942
   PubMed Web of Science ®Google Scholar
• JonesELOlesonJRProsnitzLRRandomized trial of hyperthermia and radiation for superficial tumorsJ Clin Oncol200523133079308515860867
   PubMed Web of Science ®Google Scholar
• VarmaSMyersonRMorosETaylorMStraubeWZoberiISimultaneous radiotherapy and superficial hyperthermia for high-risk breast carcinoma: a randomised comparison of treatment sequelae in heated versus non-heated sectors of the chest wall hyperthermiaInt J Hyperthermia201228758359022946861
   PubMed Web of Science ®Google Scholar
• LeeJChatterjeeDKLeeMHKrishnanSGold nanoparticles in breast cancer treatment: promise and potential pitfallsCancer Lett20143471465324556077
   PubMed Web of Science ®Google Scholar
• HirschLRStaffordRJBanksonJANanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceProc Natl Acad Sci U S A200310023135491355414597719
   PubMed Web of Science ®Google Scholar
• LooCLoweryAHalasNWestJDrezekRImmunotargeted nanoshells for integrated cancer imaging and therapyNano Lett20055470971115826113
   PubMed Web of Science ®Google Scholar
• LoweryARGobinAMDayESHalasNJWestJLImmunonanoshells for targeted photothermal ablation of tumor cellsInt J Nanomedicine20061214915417722530
   PubMed Web of Science ®Google Scholar
• GandraNPortzCNergizSZFalesAVo-DinhTSingamaneniSInherently stealthy and highly tumor-selective gold nanoraspberries for photothermal cancer therapySci Rep201551031125974150
   PubMedGoogle Scholar
• SkrabalakSEChenJAuLLuXGold nanocages for biomedical applicationsAdv Mater200719203177318418648528
   PubMed Web of Science ®Google Scholar
• AbadeerNSMurphyCJRecent progress in cancer thermal therapy using gold nanoparticlesJ Phys Chem C2016120946914716
   Web of Science ®Google Scholar
• OhEDelehantyJBSapsfordKECellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle sizeACS Nano2011586434644821774456
   PubMed Web of Science ®Google Scholar
• HuangKMaHLiuJSize-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivoACS Nano2012654483449322540892
   PubMed Web of Science ®Google Scholar
• WustPHildebrandtBSreenivasaGHyperthermia in combined treatment of cancerLancet Oncol20023848749712147435
   PubMed Web of Science ®Google Scholar
• HuangHCYangYNandaAKoriaPRegeKSynergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matricesNanomedicine (Lond)20116345947321542685
   PubMed Web of Science ®Google Scholar
• RylanderMNFengYBassJDillerKRThermally induced injury and heat-shock protein expression in cells and tissuesAnn N Y Acad Sci2005106622224216533928
   PubMed Web of Science ®Google Scholar
• BurkeARSinghRNCarrollDLThe resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapyBiomaterials201233102961297022245557
   PubMed Web of Science ®Google Scholar